Literature DB >> 12970879

Apoptosis-inducing effect of recombinant Caspase-3 expressed by constructed eukaryotic vector on gastric cancer cell line SGC7901.

Yuan-Gen Fu1, Yao-Jun Qu, Kai-Chun Wu, Hui-Hong Zhai, Zhi-Guo Liu, Dai-Ming Fan.   

Abstract

AIM: To investigate the apoptosis-inducing effect of Caspases-3 expressed by constructed eukaryotic vector on gastric cancer cell line SGC7901.
METHODS: PCR was employed to amplify the sequences of both small and large subunits of Caspases-3. Its products were separately cloned into the Sma I site of pBluescript KS(+) to generate both plasmids pBS/SS and pBS/LS. The small subunit fragment was excised from plasmid pBS/SS with BamH I and then inserted into the BamH I site of plasmid pBS/LS preceding that of the large subunit to yield plasmid pBS/Rev-Caspase-3. Rev-Caspase-3 cDNA was excised with Kpn I+Xba I and then subcloned into plasmid pcDNA3.1 (+) to construct Rev-Caspase-3 eukaryotic expression vector pcDNA/Rev-Caspase-3, which was used to transiently transfect SGC7901 cell line. Cell count, MTT assay and electron microscopy were used to confirm the antiproliferation and apoptosis-inducing effect of Rev-Caspase-3 expression on gastric cancer cells.
RESULTS: Plasmid pBS/Rev-Caspase-3 and eukaryotic expression vector pcDNA/Rev-Caspase-3 were successfully constructed. SGC7901 cells were transiently transfected by either pcDNA/Rev-Caspase-3 or pcDNA3.1 (+) for 24, 48, 72, and 96 h respectively. Cell growth was measured by cell count and MTT assay. In cell count assay, the cell numbers were 1.8 X 10(6), 1.55 X 10(6), 2.0 X 10(6), and 3.1 X 10(6) in the experimental group and 2.5 X 10(6), 3.1 X 10(6), 4.0 X 10(6), and 5.7 X 10(6) in the control group at 24, 48, 72 and 96 h respectively. The growth of SGC7901 cells was suppressed by Rev-Caspase-3 in a time-dependent manner (P<0.05). The results of MTT assay were similar to that of cell count (P<0.05). The characteristics of apoptosis such as chromatin condensation, crescent formation and margination were seen and more obvious with time in the given-experimental period in the experimental group, but not easily observed in the control group.
CONCLUSION: The expression of Rev-Caspase-3 by the constructed eukaryotic vector can significantly induce apoptosis of gastric cancer cell line SGC7901, which may exhibit a potential way in gastric cancer gene therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970879      PMCID: PMC4656647          DOI: 10.3748/wjg.v9.i9.1935

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  43 in total

Review 1.  Caspases: killer proteases.

Authors:  D W Nicholson; N A Thornberry
Journal:  Trends Biochem Sci       Date:  1997-08       Impact factor: 13.807

2.  Sequential activation of caspases and serine proteases (serpases) during apoptosis.

Authors:  Jerzy Grabarek; Litong Du; Gary L Johnson; Brian W Lee; David J Phelps; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2002 Mar-Apr       Impact factor: 4.534

3.  Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome.

Authors:  Susan M Knoblach; Maria Nikolaeva; Xiuling Huang; Lei Fan; Stanislaw Krajewski; John C Reed; Alan I Faden
Journal:  J Neurotrauma       Date:  2002-10       Impact factor: 5.269

4.  Killing effect of TNF-related apoptosis inducing ligand regulated by tetracycline on gastric cancer cell line NCI-N87.

Authors:  X C Wei; X J Wang; K Chen; L Zhang; Y Liang; X L Lin
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

5.  Apoptosis-dependent subversion of the T-lymphocyte epitope hierarchy in lymphoma cells.

Authors:  Paola Castiglioni; Alfonso Martin-Fontecha; Gabriella Milan; Valentina Tomajer; Fulvio Magni; Jakob Michaelsson; Claudio Rugarli; Antonio Rosato; Matteo Bellone
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

6.  Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.

Authors:  J P Sheridan; S A Marsters; R M Pitti; A Gurney; M Skubatch; D Baldwin; L Ramakrishnan; C L Gray; K Baker; W I Wood; A D Goddard; P Godowski; A Ashkenazi
Journal:  Science       Date:  1997-08-08       Impact factor: 47.728

7.  Apoptosis of ventricular and atrial myocytes from pacing-induced canine heart failure.

Authors:  M Y Heinke; M Yao; D Chang; R Einstein; C G dos Remedios
Journal:  Cardiovasc Res       Date:  2001-01       Impact factor: 10.787

8.  Vaccine-induced apoptosis: a novel clinical trial end point?

Authors:  S Amin; R A Robins; C A Maxwell-Armstrong; J H Scholefield; L G Durrant
Journal:  Cancer Res       Date:  2000-06-15       Impact factor: 12.701

9.  The short prodomain influences caspase-3 activation in HeLa cells.

Authors:  T Meergans; A K Hildebrandt; D Horak; C Haenisch; A Wendel
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

10.  RRR-alpha-tocopheryl succinate inhibits human gastric cancer SGC-7901 cell growth by inducing apoptosis and DNA synthesis arrest.

Authors:  Kun Wu; Yan Zhao; Bai-He Liu; Yao Li; Fang Liu; Jian Guo; Wei-Ping Yu
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

View more
  4 in total

1.  Clinical and experimental study of oxaliplatin in treating human gastric carcinoma.

Authors:  Wan-Long Lin; Ding-Guo Li; Qiang Chen; Han-Ming Lu
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

Review 2.  Gene therapy for gastric cancer: is it promising?

Authors:  Andreas P Sutter; Henry Fechner
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

3.  Comparison of caspase genes for the induction of apoptosis following gene delivery.

Authors:  Xiujuan Zhang; Curlicia Turner; W T Godbey
Journal:  Mol Biotechnol       Date:  2008-12-09       Impact factor: 2.695

Review 4.  Adenoviral gene therapy in gastric cancer: a review.

Authors:  Nima Khalighinejad; Hesammodin Hariri; Omid Behnamfar; Arash Yousefi; Amir Momeni
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.